Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Buchner

Showing results (71-80 of 207) with videos related to

Pageof 21
Sort By:
Urologia Internationalis|December 5, 2019
Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center StudyBrigitte Katharina Ziegelmueller, Jan-Friedrich Jokisch, Alexander Buchner, et al.
European Urology Focus|March 12, 2019
Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched AnalysisAlexander Kretschmer, Tobias Grimm, Alexander Buchner, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 27, 2011
Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM stagingJudith Eckl, Alexander Buchner, Petra U Prinz, et al.
Urologia Internationalis|June 27, 2019
Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological OutcomeJan-Friedrich Jokisch, Tobias Grimm, Alexander Buchner, et al.
European Urology Focus|June 15, 2020
Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?Severin Rodler, Maria Apfelbeck, Gerald Bastian Schulz, et al.
World Journal of Urology|May 19, 2017
"Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP)Annika Herlemann, Kerstin Wegner, Alexander Roosen, et al.
Stem Cells (Dayton, Ohio)|May 1, 2013
CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasisMaximilian Gassenmaier, Dong Chen, Alexander Buchner, et al.
Urologia Internationalis|January 21, 2021
Does Pandemic Anxiety Affect Urology Health Care Workers?Maria Apfelbeck, Michael Staehler, Severin Rodler, et al.
Patient Preference and Adherence|December 16, 2024
Phytomedicines in Pharmacotherapy of LUTS/BPH - What Do Patients Think?Alexander Tamalunas, Richard Paktiaval, Philipp Lenau, et al.
Plos One|July 9, 2011
Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapyRobert Kammerer, Alexander Buchner, Patrick Palluch, et al.
Pageof 21

Showing results (71-80 of 207) with videos related to

Sort By:
Pageof 21
Urologia Internationalis|December 5, 2019
Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center StudyBrigitte Katharina Ziegelmueller, Jan-Friedrich Jokisch, Alexander Buchner, et al.
European Urology Focus|March 12, 2019
Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched AnalysisAlexander Kretschmer, Tobias Grimm, Alexander Buchner, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 27, 2011
Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM stagingJudith Eckl, Alexander Buchner, Petra U Prinz, et al.
Urologia Internationalis|June 27, 2019
Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological OutcomeJan-Friedrich Jokisch, Tobias Grimm, Alexander Buchner, et al.
European Urology Focus|June 15, 2020
Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?Severin Rodler, Maria Apfelbeck, Gerald Bastian Schulz, et al.
World Journal of Urology|May 19, 2017
"Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP)Annika Herlemann, Kerstin Wegner, Alexander Roosen, et al.
Stem Cells (Dayton, Ohio)|May 1, 2013
CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasisMaximilian Gassenmaier, Dong Chen, Alexander Buchner, et al.
Urologia Internationalis|January 21, 2021
Does Pandemic Anxiety Affect Urology Health Care Workers?Maria Apfelbeck, Michael Staehler, Severin Rodler, et al.
Patient Preference and Adherence|December 16, 2024
Phytomedicines in Pharmacotherapy of LUTS/BPH - What Do Patients Think?Alexander Tamalunas, Richard Paktiaval, Philipp Lenau, et al.
Plos One|July 9, 2011
Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapyRobert Kammerer, Alexander Buchner, Patrick Palluch, et al.
Pageof 21